68-5

79/120

) Okabe T, Togo S, Fujimoto Y, Watanabe J, Sumiyoshi I, Orimo A, Takahashi K: Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy. Cancers(Basel), 2020; 12: 3588.) Seyama K, Kurihara M: Chapter 16. Pleural Disease in Diffuse Cystic Lung Diseases. In: Cystic Lung Diseases. Cancer and lymphatic metastasis. Gupta N (eds), Springer Nature, 2020 in press.) Makita Y, Suzuki H, Kano T, Takahata A, Julian BA, Novak J, Suzuki Y: TLR9 activa‑tion induces aberrant IgA glycosylation via APRIL-and IL-6-mediated pathways in IgA nephropathy. Kidney Int, 2020; 97: 340-349.) Gohda T, Kamei N, Koshida T, Kubota M, Tanaka K, Yamashita Y, Adachi E, Ichikawa S, Murakoshi M, Ueda S, Suzuki Y: Circu‑lating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease. J Diabetes Invest, 2020; 11: 435-440.Shibayama K, Sumiyoshi I, Ochi Y, Iwai M, Okabe T, Chonan M, Misawa S, Ohsaka A, Takahashi K: The synergetic effect of Imipe‑nem-clarithromycin combination the Mycobacteroides abscessus complex. BMC Microbiol, 2020; 20: 316. 31) Okuma Y, Ko R, Shukuya T, Tateishi K, Imai H, Iwasawa S, Miyauchi E, Kojima T, Fujita Y, Hino T, Yamanda S, Suzuki T, Fukuizumi A, Sakakibara T, Harada T, Morita S, Kobayashi K, Nukiwa T, Takahashi K: North East Japan Study Group. Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy. Lung Cancer, 2020; 148: 122- 128. 32) Kato M, Takahashi F, Sato T, Mitsuishi Y, Tajima K, Ihara H, Nurwidya F, Baskoro H, Murakami A, Kobayashi I, Hidayat M, Shimada N, Sasaki S, Mineki R, Fujimura T, Kumasaka T, Niwa S, Takahashi K: Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway. Drug Des Devel Ther, 2020; 14: 4593-4603. 33) Sata N, Inoshita A, Suda S, Shiota S, Shiro‑shita N, Kawana F, Suzuki Y, Matsumoto F, Ikeda K, Kasai T: Clinical, polysomnographic, and cephalometric features of obstructive sleep apnea with AHI over 100. Sleep Breath, 2020; doi: 10.1007/s11325-020-02241-8. Online ahead of print. 34) Kurokawa K, Harada N, Sasano H, Takahagi H, Takei S, Nakamura A, Kamada K, Yoshida A, Kikuchi K, Takahashi K: Pulmonary infec‑tion due to fluoroquinolone-resistant Mycol‑icibacterium fortuitum: a case report. BMC Infect Dis. 2020; 20: 866. 35) Hayashi T, Kohsaka S, Takamochi K, Kishi‑kawa S, Sano K, Hara K, Suehara Y, Taka‑hashi F, Saito T, Suzuki K, Yao T: Histolog‑ical Characteristics of Lung Adenocarcinoma With Uncommon Actionable Alterations: Special Emphasis on MET exon 14 Skipping Alterations. Histopathology, 2020. doi: 10.1111/ his.14311. Online ahead of print. 36) Shukuya T, Ghai V, Amann JM, Okimoto T, Shilo K, Kim TK, Wang K, Carbone DP: Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC. J Thorac Oncol, 2020; 15: 1773-1781.in 37) Kogami M, Suzuki S, Nanjo Y, Ikeda K, Tamura N, Sasaki S, Morimoto S: Complica‑tion of coronavirus disease 2019 during remission induction therapy against anti- MDA5 antibody-positive dermatomyositis. Rheumatol Adv Pract, 2020; 4: rkaa068. 38) Kurata K, Matsumoto H, Jimbo N, Yakushijin K, Yamamoto K, Ito M, Nakamachi Y, Matsuoka H, Saegusa J, Seyama K, Itoh T, Minami H: Lymphoplasmacytic lymphoma in a patient with Birt-Hogg-Dubé syndrome. Int J Hematol, 2020; 112: 864-870. 39) Miyazaki K, Togo S, Okamoto R, Idiris A, Kumagai H, Miyagi Y: Collective cancer cell invasion in contact with fibroblasts through integrin-α5β1/fibronectin in collagen matrix. Cancer Sci, 2020; 111: 4381-4392.〈Reviews〉 1〈Books〉 1Nephrology〈Original Articles〉 1 2interaction 529